CBU
OCUL icon

CIBC Bancorp USA’s Ocular Therapeutix OCUL Stock Holding History

CIBC Bancorp USA’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$191K Buy
19,408
+1,901
+11% +$17.2K ﹤0.01% 1792
2026
Q1 		$148K Buy
+17,507
New +$167K ﹤0.01% 1656
2025
Q3 		$175K Buy
+14,985
New +$179K ﹤0.01% 1293

Other funds holding OCUL

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

CIBC Bancorp USA's OCUL Position: Q2 2026 in Review

CIBC Bancorp USA increased its Ocular Therapeutix (OCUL) stake by 11% in Q2 2026, buying an estimated $17.2K and bringing the position to 19,408 shares worth $191K. The position accounts for ﹤0.01% of the portfolio, ranked #1792.

CIBC Bancorp USA first reported a position in OCUL in Q3 2025 and has held it in 3 quarters since. 237 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • CIBC Bancorp USA held 19,408 shares of Ocular Therapeutix worth $191K as of Q2 2026.
  • CIBC Bancorp USA bought 1,901 Ocular Therapeutix shares in Q2 2026, an estimated $17.2K.
  • Ocular Therapeutix made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1792 holding.
  • CIBC Bancorp USA first reported a position in Ocular Therapeutix in Q3 2025 and has held it in 3 quarters since.
  • 237 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.